• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.

作者信息

Sobel B E, Geltman E M, Tiefenbrunn A J, Jaffe A S, Spadaro J J, Ter-Pogossian M M, Collen D, Ludbrook P A

出版信息

Circulation. 1984 May;69(5):983-90. doi: 10.1161/01.cir.69.5.983.

DOI:10.1161/01.cir.69.5.983
PMID:6608420
Abstract

To assess the effects on the heart itself of coronary thrombolysis induced with either tissue-type plasminogen activator (t-PA) or streptokinase (SK), we performed positron emission tomography with 11C-palmitate in 19 patients with initial transmural myocardial infarction immediately after admission and again within 48 to 72 hr after intracoronary administration of t-PA (n = 2) or SK (n = 17). Clots were persistent in eight patients treated with SK despite an average dose of 336,000 IU, sufficient to markedly deplete fibrinogen. In the absence of lysis, favorable tomographic changes did not occur. In contrast, in each of the 11 patients in whom lysis was induced (two with t-PA and nine with SK) myocardial accumulation of 11C-palmitate improved by an average of 29% in late compared with early studies (p less than .001). Results were comparable in patients with anterior and those with inferior infarction. Thus clot lysis induced with either t-PA or SK led to improved regional myocardial metabolism.

摘要

相似文献

1
Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.
Circulation. 1984 May;69(5):983-90. doi: 10.1161/01.cir.69.5.983.
2
Clot-selective coronary thrombolysis with tissue-type plasminogen activator.使用组织型纤溶酶原激活剂进行冠状动脉血栓选择性溶栓治疗。
Science. 1983 Jun 10;220(4602):1181-3. doi: 10.1126/science.6602378.
3
Coronary thrombolysis with clot-selective plasminogen activators.使用凝块选择性纤溶酶原激活剂进行冠状动脉溶栓治疗。
Herz. 1986 Feb;11(1):9-15.
4
Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.组织型纤溶酶原激活剂用于进展性心肌梗死患者的冠状动脉溶栓治疗。
N Engl J Med. 1984 Mar 8;310(10):609-13. doi: 10.1056/NEJM198403083101001.
5
Coronary thrombolysis for evolving myocardial infarction.进展性心肌梗死的冠状动脉溶栓治疗。
Drugs. 1984 Nov;28(5):465-83. doi: 10.2165/00003495-198428050-00004.
6
[New thrombolytic agents in myocardial infarction].[心肌梗死中的新型溶栓药物]
Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91.
7
[Platelet activation in the early phases of acute myocardial infarction].[急性心肌梗死早期阶段的血小板活化]
Cardiologia. 1998 Aug;43(8):825-32.
8
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography.以正电子断层扫描为特征的冠状动脉溶栓有益效果的时间依赖性
Am J Med. 1982 Oct;73(4):573-81. doi: 10.1016/0002-9343(82)90338-2.
9
Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.正电子断层扫描检测到的充血性心肌病患者局部心肌代谢改变。
Am J Med. 1983 May;74(5):773-85. doi: 10.1016/0002-9343(83)91065-3.
10
New developments in thrombolytic therapy.溶栓治疗的新进展。
Adv Exp Med Biol. 1990;281:333-54.

引用本文的文献

1
Progress in cardiovascular care: a heart-felt thanks to our forebears.心血管护理的进展:衷心感谢我们的前辈。
Mo Med. 2010 Jan-Feb;107(1):19-24.
2
Coronary thrombolysis with tissue-type plasminogen activator: prospective review.组织型纤溶酶原激活剂用于冠状动脉溶栓:前瞻性综述。
Tex Heart Inst J. 1984 Dec;11(4):344-7.
3
Radionuclide techniques for the assessment of myocardial viability.用于评估心肌活力的放射性核素技术。
Tex Heart Inst J. 1998;25(4):272-9.
4
Assessment of myocardial fatty acid metabolism with 1-11C-palmitate.用1-¹¹C-棕榈酸评估心肌脂肪酸代谢。
J Nucl Cardiol. 1994 Mar-Apr;1(2 Pt 2):S15-22. doi: 10.1007/BF02940064.
5
Cardiac positron emission tomography.心脏正电子发射断层扫描
West J Med. 1985 Dec;143(6):764-72.
6
Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator.冠状动脉溶栓与促进肌肉注射组织型纤溶酶原激活剂的吸收
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4258-62. doi: 10.1073/pnas.82.12.4258.
7
Cardiac nuclear medicine, present status, future hopes as seen from the view of a cardiologist.
Eur J Nucl Med. 1988;13(12):606-11. doi: 10.1007/BF00256388.
8
Clinical applications of assessments of myocardial substrate utilization with positron emission tomography.正电子发射断层扫描评估心肌底物利用的临床应用
Mol Cell Biochem. 1989;88(1-2):201-9. doi: 10.1007/BF00223445.